17)
. Although caries is a polymicrobial disease caused by a dysbiosis in the dental plaque 48 microbial community, Streptococcus mutans, with its copious acid production and prodigious 49 biofilm formation, is still considered a primary etiologic agent (18, 19) . To persist in the dental 50 3 plaque community and cause disease, S. mutans must be able to outcompete commensal 51 bacteria directly. 52
Small molecules produced by BGCs are increasingly recognized to play major roles in 53 species-species communication and interactions (10, 13) , and a recent study predicted 355 strain-54 specific BGCs across 169 S. mutans genomes (20) . Although the production of mutactins (a group 55 of bacteriocins) has been recognized for contribution to the colonization and establishment of S. 56 mutans in the dental biofilm(21), the roles of other genetically encoded small molecules in S. 57 mutans is barely explored, with exception of the mutanobactins. Mutanobactins are compounds 58 of hybrid polyketide synthase and nonribosomal peptide synthetase (PKS/NRPS) origin that 59 inhibit the morphological transition of Candida albicans (22) . Previous bioinformatics efforts 60 identified an orphan hybrid PKS/NRPS BGC (recently designated muc) (20, 23) , that is distributed 61 among a subset of S. mutans strains. Within muc, five biosynthetic proteins are highly 62 homologous (48%-69%) to cognates involved in the biosynthesis of reutericyclin (RTC)(24) 63 ( Supplementary Fig. 1 and Fig. 1a) . RTC, which originated from the sourdough isolates of 64 Lactobacillus reuteri, acts as a proton ionophore antibiotic that modulates the microbial 65 community of sourdough (25, 26) . Interestingly, we found that S. mutans strains encoding muc 66 were dispersed geographically and frequently associated with severe dental caries 67
( Supplementary Table 1 ). The goal of this study was to determine whether muc produces RTC 68 or RTC-like molecules, and if these molecules can affect inter-species competition in the oral 69 cavity. 70
To determine the product of muc, we utilized homologous recombination to delete the 71 gene mucD, which encodes an assembly line NRPS tridomain protein (Fig. 1a) . We conducted 72 all our biosynthetic experiments in S. mutans B04Sm5, a strain bearing muc, which was isolated 73 from a child with severe early childhood caries(27). The wild type (WT) strain and ∆mucD mutant 74 were cultured and extracted for HPLC analyses. The results showed that the WT strain produced 75 four metabolites not present in the ∆mucD mutant ( Fig. 1b) . These molecules were purified via 76 preparative HPLC (Supplementary Note 1) and characterized by High-Resolution Mass 77 Spectrometry (HR-MS/MS), chemical synthesis, and/or one-and two-dimensional Nuclear 78
Magnetic Resonance (NMR) experiments to yield a group of tetramic acids, including RTC 79 (renamed RTC A, 1), two new RTC analogues (RTC B (2) and RTC C (3)), and a new organic 80 acid (4) ( Fig. 1c, Supplementary Note 1, Supplementary Tables 2-3, Supplementary Figs. 2-81   22 ). During preparation of this manuscript, Chen and colleagues published the identification of 4 82 (designated mutanocyclin (MUC)) using a new heterologous genetic system(23); however, 83 production of 1-3 in both heterologous host and wild type producers was not reported. 84
Muc is a ∼13 kb hybrid NRPS-PKS pathway encoding nine proteins (Supplementary 85 Table 5 ). In silico analysis revealed that mucD to mucE encode the core assembly line protein 86 machinery ( Fig. 1a and Fig. 2a ). While MucD is a C-A-T tridomain protein, with specificity for 87 adenylating leucine, MucE contains an KS-T-TE module, as commonly present in the termination 88 modules of PKS assembly lines. Based on the enzymatic logic of thiotemplate-mediated assembly 89 line biosynthesis, we propose that 1-3 are assembled, respectively, from trans-2-decenoyl-ACP, 90 decenoyl-ACP, and trans-2-dodecenoyl-ACP starter units through elongation with leucine, 91 followed by elongation with a malonyl-CoA extender unit ( Fig. 2a) . Inspection of structures of 1-3 92 suggested that the A domain of MucD appears to install a D-leucine residue into the final product. 93
To explore this hypothesis, we fed both [ 13 C1] L-and D-leucine to cultures of S. mutans B04Sm5. 94 MS analyses of the purified 1 and 3 only revealed the incorporation of [ 13 C1] L-leucine 95 ( Supplementary Figs. 23-24 ). The same result was observed by feeding the original RTC 96 producer L. reuteri with the same isomers ( Supplementary Fig. 25) . These results indicate that 97 an unrecognized epimerization reaction is involved in 1-3 biosynthesis; however, no standard 98 epimerization (E) domain or dual functioning C/E domains could be found either in the assembly 99 line or encoded elsewhere in the BGC. Additionally, although a dual-function TE/E domain has 100 been characterized from the nocardicin (NOC) biosynthetic assembly line(28), MucTE shows very 101 low homology (20%/35%, identity/similarity) to the dual functioning NocTE domain. 102 5
The first three genes (mucA-C) encode a hydroxymethylglutaryl-CoA synthase (MucA), a 103 thiolase (MucB), and a hypothetical protein (MucC) ( Supplementary Table 5 ), which show 104 homology to the three submits (PhlA, PhlB and PhlC, respectively) of a multicomponent C-105 acetyltransferase involved in the acetylation of the type III PKS product phloroglucinol from 106
Pseudomonas fluorescens Q2-87(29, 30) . As the combination of the three genes was also 107 identified in rtc (rtcA, rtcC and rtcB) from L. reuteri (24), the function of MucA-C is consistent with 108 introducing the acetyl group to the pyrrolidine ring of 1-3 ( Fig. 2a) . We additionally annotated four 109 genes downstream of the mucA-E operon encoding a small HXXEE domain-containing 110 membrane-protein (MucF) of unknown function, two TetR/AcrR family transcriptional regulators 111 (MucG and MucH), and one multidrug efflux pump (MucI) ( Supplementary Table 5 ). Presumably, 112 they are not involved in the direct synthesis of 1-3. To verify this hypothesis, we cloned the operon 113 from mucA to mucE into the pACYCDuet-1 vector to generate the plasmid pEXT06, in which the 114 operon is exclusively under control of a T7 promoter. As expected, expression of mucA-E in 115
Escherichia coli BAP1 strain resulted in the production of at least four products, including 1-3 and 116 new compound 5 ( Fig. 2b and Supplementary Fig. 26 ). 5 was purified via preparative HPLC and 117 its structure was further confirmed as a new RTC analogue (RTC D) possessing a saturated C-118 12 fatty acid side chain by MS and NMR analyses ( Supplementary Table 4 , Supplementary 119 Fig. 26 and Supplementary Figs. 27-30 ). This result indicates that the first six genes mucA-E 120 indeed compose the minimal BGC for 1-3 production ( Fig. 2a) . 121
As the structure of 4 is consistent with the RTC core lacking the fatty acyl chain, we first 122 set out to detect whether the free fatty acid, trans-2-decenoic acid per compound 1, is present in 123 the extract of S. mutans B04Sm5. HPLC analyses confirmed that S. mutans B04Sm5 readily 124 produced trans-2-decenoic acid (Supplementary Fig. 31 ). In contrast, it was not detected in the 125 pathway-deficient mutant S. mutans B04Sm5/∆mucD. These findings suggested that 4 may be 126 derived from 1-3 via deacylation by an unknown enzyme. Interestingly, trans-2-decenoic acid is 127 a known Streptococcus diffusible signal factor (SDSF) isolated from many Streptococcus 128 species(31), which inhibits the hyphal formation of the opportunistic fungus Candida albicans. 129
Among the annotated pathway enzymes, only the function of MucF was unassigned. The MucF 130 protein sequence was subjected to a secondary structure prediction-based homology search 131 (Phyre2), which suggested it is a polytopic (five) transmembrane α-helical protein 132 ( Supplementary Fig. 32 ) with low similarity (15%) to a viral protein (PDB 3LD1) with putative 133 hydrolase activity. To explore whether MucF might be involved in the deacylation of 1-3, we 134 generated a mucF deletion mutant in S. mutans B04Sm5. HPLC analysis of the extract of mutant 135 cultures showed that the ∆mucF mutant not only increased the production of 1-3 by ~3-5 fold, but 136 also lost the ability to produce 4 ( Fig. 1b) . These findings strongly suggested that MucF is 137 essential for converting 1-3 to 4. To further evaluate the function of MucF, we cloned and 138 expressed mucF in E. coli and incubated 1 with the E. coli/mucF cell lysate, leading to the in vitro 139 production of the deacylated 4 ( Fig. 2c) . In contrast, no conversation was detected in the control 140 experiment (E. coli carrying empty vector) ( Fig. 2c) . To further support this observation, we 141 inserted a copy of mucF into the secondary expression site of pEXT06, resulting in the plasmid 142 pEXT07. Its expression in E. coli BAP1 further led to the formation of 4 ( Fig. 2b) . Collectively, 143 these mutations, in vitro, and in vivo expression studies support the hypothesis that MucF is a 144 newly recognized deacylase responsible for converting 1-3 to 4. Notably, MucF showed sequence 145 similarity to a large group of hypothetical proteins from the genomes of bacteria associated with 146 the human gut and skin (Supplementary Fig. 33 ). We therefore speculate MucF joins a large 147 family of unrecognized deacylases that may play important roles within the human microbiota. 148
Next, we took two approaches to determine whether RTCs and MUC play roles in 149 mediating inter-species bacterial competition. Frist, we used a plate-based competition assay, in 150 which a colony of S. mutans UA159 (a model organism for caries disease), S. mutans B04Sm5 151 (producing 1-4), S. mutans B04Sm5/∆mucD (1-4 deficient strain), or S. mutans B04Sm5/∆mucF 152 (producing 1-3 exclusively) was plated next to nascent colonies of other oral bacteria, including 7 3). In general, S. mutans B04Sm5 exhibited greater inhibition of neighbors than the S. mutans 155 model strain UA159. In contrast, S. mutans B04Sm5/∆mucD, which lacks the production of 156 compounds 1-4, dramatically exhibited reduced inhibition of its neighbors. For instance, S. mutans 157
B04Sm5 impaired the growth of S. sanguinis completely, while S. mutans B04Sm5/∆mucD only 158 showed slight inhibition of S. sanguinis. Furthermore, although the growth of S. mutans 159
B04Sm5/∆mucF was impaired by overproducing 1-3, it exhibited the strongest inhibition of 160 neighbors among all tested strains. S. sanguinis is one of the predominant species of the 161 indigenous oral biota colonizing dental plaque, which is normally associated with healthy dental 162 biofilm(32). The antagonistic relationship between S. sanguinis and S. mutans is well-163 characterized, and plays an important role in caries development (33, 34) . Therefore, we 164 determined the Minimum Inhibitory Concentration (MIC) of isolated 1 and 4 against the S. 165 sanguinis ATCC 49296. Remarkably, we observed significant antibacterial activity of 1 against 166 the S. sanguinis (MIC=3.1 µM), However, 4 did not show any antibacterial activities against S. 167 sanguinis up to a concentration of 2 mM. These results provide compelling support that the muc 168 pathway, through compounds 1-3, provides a competitive advantage for S. mutans B04Sm5 by 169 inhibiting the growth of its competitors. The increased competitive fitness conferred by muc is 170 likely to increase the virulence S. mutans strains bearing the gene cluster. As S. mutans is an 171 exceptionally productive biofilm-former, higher numbers of S. mutans are likely to increase plaque 172 biofilm formation and promote the dysbiosis which leads to the formation of caries lesions. 173
Interestingly, Chen and colleagues showed that 4 can significantly suppress the infiltration of 174 leukocytes (CD45 + cells) into the Matrigel plug in a mice model, suggesting an anti-inflammatory 175 activity(23). 176
In summary, we describe a versatile biosynthetic pathway from an oral pathogen S. 177 mutans B04Sm5, which can produce three types of compounds with divergent biological activities. 178
These include three N-acyl tetramic acids (1-3) that display antibacterial properties against oral 179 commensal bacteria, a new organic acid (4) with a reported anti-inflammatory activity in a mice 180 model(23), and a previously characterized SDSF with the ability to interact with pathogenic oral 181 fungi(31). Although two antibiotics have been discovered from the commensal bacteria of human, 182
including lactocillin(13) and lugdunin(35), RTCs, to our knowledge, are the first group of low 183 molecular weight antibacterial molecules identified from a human opportunistic pathogen. While 184 this study merely scrapes the "tip of the iceberg" of the recently identified oral biosynthetic 185 potential(13, 36), these findings clearly exemplify that deeper exploration of leads provided by 186 genome mining studies will help elucidate the complex ecological underpinnings of the human 187 microbiome and its relationship to disease. 188
189

METHODS
190
General methods. A complete list of the primers, plasmids, and strains used in this study can be 191 found in Supplementary Table 6 . PCR products were amplified with PrimeSTAR HS DNA 192 polymerase (Clontech Laboratories, Inc., USA). DNA isolations and manipulations were carried 193 out using standard protocols. Escherichia coli strains were cultivated in LB medium (Thermo 194 Fisher Scientific, USA) supplemented with appropriate antibiotics. S. mutans B04Sm5 and its 195 respective derivatives were all grown on Brain Heart Infusion (BHI) agar or liquid medium (BD 196 Biosciences, USA) at 37 °C in a CO2 incubator (5% CO2/95% air). Lactobacillus reuteri LTH2584 197 was also grown on MRS medium (BD Biosciences, USA) or agar at 37 °C in a CO2 incubator (5% 198 CO2). 199 200 Production, extraction, and detection of reutericyclins (1-3) and mutanocyclin (4) from S. 201 mutans. 50 milliliters of BHI medium were inoculated with a loop of glycerol stock of S. mutans 202 or a mutant thereof overnight. Thirty milliliters of preculture was inoculated into 3 liters of BHI 203 medium containing 1% glucose. After 12 hours incubation, 60 g of autoclaved Amberlite XAD7-204 HP resin (Sigma-Aldrich, USA) was added to the cultures. The cultures were incubated for 205 another 36 hours at 37 °C in a CO2 incubator (5% CO2). The resin was recovered and washed 206 twice with water (200 mL) and the extract was subsequently extracted twice with ethyl acetate 207 (400 mL in total). The organic phase was evaporated, and extracts were dissolved in 2 mL 208 methanol. Each extract was monitored at 280 nm during separation by HPLC using a Kinetex® 209 Table 6 ). The left (532 bp) and right (555 bp) flanks of mucD were 216 amplified from the genomic DNA of S. mutans B04Sm5 with the primer pairs of mucD_KO_L-217 fwd/mucD_ KO_L-rev and mucD_ KO_R-fwd/mucD_ KO_R-rev (Supplementary Table 6) , 218 respectively. These three PCR products were assembled with a double digested pUC19 (PstI and 219 EcoRI) using a NEBuilder HiFi DNA Assembly kit (New England Biolabs, USA), which resulted in 220 the vector pEXT01. Amplification of the left (602 bp) and right (611 bp) homology arms for 221 knocking out mucF were accomplished with primer pairs mucF_ KO_L-fwd/mucF_ KO_L-rev and 222 mucF_ KO_R-fwd/mucF_ KO_R-rev (Supplementary Table 6) , respectively. These two PCR 223 products and spec R cassette were further cloned into pUC19 to give pEXT02 using the method 224 described above. Vector clones were verified by restriction analysis and sequencing. 225 226 Generation of ΔmucD and ΔmucF mutants. The disruption cassettes were amplified from 227 pEXT01 (2159 bp) and pEXT02 (2159 bp) using primer pairs mucD_KO_L-fwd/mucD_ KO_R-rev 228 and mucF_ KO_L-fwd/mucF_ KO_R-rev (Supplementary Table 6) , respectively. PCR products 229
were digested by DpnI and then purified using the QIAquick PCR Purification Kit (Qiagen, USA). 230
The disruption cassettes were transferred to S. mutans B04Sm5 by a previously reported 231 protocol(38). Spectinomycin resistance clones were selected by growth on BHI agar 232 supplemented with 500 μg/mL spectinomycin, confirmed by PCR and sequencing, and 233 designated as S. mutans B04Sm5/∆mucD and S. mutans B04Sm5/∆mucF. 234 235 Generation of muc expression plasmid. The 8.6-kb DNA region containing mucA-E was PCR 236 amplified from the genomic DNA of S. mutans B04Sm5 in two fragments (each approximately 4 237 kb) with primer pairs mucA-E_ fwd1/ mucA-E_rev1 and mucA-E_fwd2/ mucA-E_rev2 238
( Supplementary Table 6 ). These fragments were cloned into the XhoI site of pACYCDuet-1 by 239 a NEBuilder HiFi DNA Assembly kit (New England Biolabs, USA), resulting in the plasmid pEXT06. 240
To construct pEXT07, mucF was amplified with primers mucF-coexp_fwd and mucF_coexp_rev. 241 PCR product and pEXT06 were digested with the restriction enzyme pair NcoI/BamHI and ligated 242 with T4 DNA ligase (New England Biolabs, USA). The resulting vectors were verified by restriction 243 analysis and sequencing. pEXT06 and pEXT07 were transformed into E. coli BAP1, respectively. 244 245 Expression, extraction, and detection of muc expression in E. coli BAP1. E. coli BAP1(39) 246 containing pEXT06 or pEXT07 were cultivated on LB plates supplemented with 1% glucose and 247 50 μg/mL chloramphenicol at 37 °C. The following day, a loop of E. coli cells was transferred for 248 precultures grown at 37 °C in 10 mL LB medium supplemented with 1% glucose and 50 μg/mL 249 chloramphenicol for 4-5 h. One microliter of each preculture was transferred to 50 mL of fresh LB 250 with the same supplements and grown at 37 °C to an OD600 of 0.4 to 0.6. Cultures were induced 251 with 200 µM IPTG and incubated for an additional 12-14 h at 30°C with shaking (220 rpm). 252
Cultures were harvested and 1 mL of H2O supplemented with 0.5 mg/mL lysozyme was added to 253 the pellets. Cells were disrupted by sonication at room temperature. The lysates were acidified 254 with acetic acid (1% final concertation) and extracted by twice with an equal volume of EtOAc. 255
The organic phase was evaporated, resuspended in MeOH (0.2 mL), and filtered through 256
Acrodisc MS PTFE Syringe filters (Pall Inc., Ann Arbor, MI, USA) prior to HPLC analysis. Each 257 extract was monitored at 280 nm during separation by HPLC using a Kinetex® C18 100 Å, LC 258
Column (5 μm, 150 × 2.1 mm; Phenomenex, US) as follows: 0-10 min, 30% B; 10-11 min, 30%-259 100% B; 11-25 min, 100% B; 26-27 min, 100%-30% B; 28-35 min, 30% B (solvent A: H2O/TFA 260 (999:1, v/v); solvent B: CH3CN/TFA (999:1)). 261
Feeding experiments for biosynthetic pathway study. S. mutans B04Sm5 was cultivated in 262 50 mL BHI medium supplemented with 1% glucose and 200 mg/L isotope-labeled [ 13 C1] L-or D-263 leucine (Sigma-Aldrich, USA). The compounds were extracted and isolated using the method 264 described above. Each extract prepared was dissolved in 100 µL MeOH for MS analysis using 265 the method described in the supplementary information (Supplementary Note 1) . 266 267 Expression and activity mensuration of MucF in E. coli. Primer pair mucF_pET_fwd/mucF_ 268 pET_rev ( Supplementary Table 6 ) was used for amplification of mucF from the genomic DNA of 269 S. mutans B04Sm5. The PCR product was cloned into the NcoI and XhoI sites of pET28a to 270 obtain pEXT26 (with a C-terminal His-tag). Next, pET28a and pEXT26 were transferred into E. 271 coli Rosetta2 TM (DE3)pLys, respectively. Single clones were picked for precultures grown 272 overnight at 37°C in TB broth (Thermo Fisher Scientific, USA) with 50 μg/mL kanamycin and 273 50μg/mL chloramphenicol at 37°C. One microliter of preculture was transferred to 1 L of fresh TB 274 broth with the same antibiotics and grown at 37°C to an OD600 of 0.4 to 0.6. Cultures were 275 induced with 500 µM IPTG and incubated for an additional 16 h at 18°C with shaking (220 rpm). 276
Cultures were harvested and 10 mL of buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 10% glycerol) 277 supplemented with 0.5 mg/mL lysozyme and 0.5 mM PMSF was added to the pellets. Cells were 278 disrupted by sonication at 4°C. The lysate was used for MucF activity testing. The assay mixture 279 for the reaction (100 μL) consisted of 96 μL E. coli lysate (both carrying empty pET28a or pEXT26) 280 and 4 μl reutericyclin A (1) solution (6.6 mM, 80% EtOH). The reaction solutions were prepared 281 on ice and incubated at 37°C for 10 min, 30 min and 60 min. Reactions were terminated by the 282 addition of 1 μL acetic acid and then extracted twice with 200 μL EtOAc. After centrifugation of 283 the assay at 12,000 g for 10 min, the organic phase was evaporated and resuspended in 100 μL 284 MeOH (0.2 mL). The extracts were monitored by HPLC. 285 286 Agar plate-based assays. The interspecies competition assays with S. mutans (UA159,
287
B04Sm5, ∆mucD, ∆mucF), R. mucilaginosa, S. gordonii, and S. sanguinis, S. mitis, S. 288 pneumoniae, and S. salivarius were performed as described previously (40), with some 289 modifications. 8 µl of overnight cultures of S. mutans strains were inoculated onto BHI agar and 290 incubated at 37°C under a 5% CO2/95% air atmosphere (vol/vol). After a 24 h incubation period, 291 an overnight culture of the indicated competing species was inoculated next to the S. mutans and 292 the plates were incubated for an additional 24 h and subsequently photographed. 
